Therapeutic advances in<scp>BIG</scp>3‐<scp>PHB</scp>2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
Tetsuro Yoshimaru(Tokushima University), Toyomasa Katagiri(The University of Tokyo)
Cited by 15
Related Papers
PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer
|Cancer Research|2006|180
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
|Breast Cancer Research|2007|167
Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
|Nature Communications|2013|80